A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
This research study is looking at a new medicine called nipocalimab for adults who have a condition called generalised myasthenia gravis, or gMG. gMG causes muscles to become weak and tired easily. The main aim of the study is to find out how well nipocalimab works compared to a 'dummy' medicine (placebo) and whether it is safe to use. The study also includes a smaller part to see how the body handles nipocalimab when it's given as an injection just under the skin, compared to giving it through a drip into a vein. This helps researchers understand the best way to give the medicine. Participants will either receive the active medicine or the placebo, and their health and symptoms will be carefully monitored throughout the study.
Överblick
Resultat
Resultat från denna studie
Publicerad Juli 2025Resultaten har publicerats för denna studie.
Vad handlar denna studie om?
This research study is about a muscle weakness condition called generalised myasthenia gravis (gMG). If you have gMG, your body's immune system mistakenly attacks healthy connections between your nerves and muscles, leading to muscle weakness that can affect things like your eyes, face, throat, and limbs. This can make everyday activities quite challenging.
The study is testing a new medicine called nipocalimab. Researchers want to see if this medicine can help improve the symptoms of gMG and make a real difference to people's lives. To do this, they will compare nipocalimab to a 'dummy' treatment (called a placebo), which looks exactly like the real medicine but contains no active ingredients. This comparison helps them understand if any changes are truly due to nipocalimab or might have happened anyway.
Another important part of this study is looking at how nipocalimab works when given in different ways. Some participants will receive the medicine through a drip into a vein, which is a common way to give medicines. Others will receive it as an injection just under the skin. This helps the researchers figure out the most effective and convenient way to deliver the medicine, which could be very helpful for future patients.
Viktiga punkter
- This study is testing a new medicine, nipocalimab, for generalised myasthenia gravis (gMG).
- It aims to see if nipocalimab is safe and effective compared to a dummy treatment (placebo).
- The medicine might be given through a drip or as an injection under the skin.
- Participation involves regular clinic visits for treatments, tests, and symptom checks.
- You will be closely monitored, and your care team will track your health.
- You can withdraw from the study at any point without affecting your regular medical care.
Vem kan vara berättigad?
To join this study, adults must have a confirmed diagnosis of generalised myasthenia gravis (gMG) that affects various muscles in their body, not just a mild form. You would need to be experiencing specific levels of muscle weakness in your daily activities according to a special scale.
The study also has some rules about other health conditions. For example, you can't have certain problems with your immune system or a history of a 'myasthenia crisis' recently. If you've had surgery to remove your thymus gland, there's a time limit for when you can join after that surgery. Also, if you know you're allergic to nipocalimab or its ingredients, you wouldn't be able to take part.
For women who could become pregnant, special pregnancy tests are required, and male participants must agree not to donate sperm during the study and for a period after. If you're considering the part of the study where the medicine is given as an injection under the skin, you'd need suitable skin on your tummy for the injections and be able to keep your regular medications for gMG stable for the first few weeks.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Do I have a confirmed diagnosis of generalised myasthenia gravis (gMG)?
- Are my gMG symptoms affecting my daily activities to a certain degree?
- Have I had a thymectomy (surgery to remove my thymus gland) more than a year ago?
- Do I have any specific immune problems or allergies that might stop me from joining?
- Am I willing to attend regular clinic visits and follow the study instructions?
Vad innebär deltagande?
If you decide to take part in this study, you'll be assigned to either receive the new medicine, nipocalimab, or a placebo (a dummy medicine). You won't know which one you're getting, and neither will your study doctor. Depending on which group you're in, the medicine could be given through a drip into a vein or as an injection under your skin. This will involve regular visits to the study clinic for these treatments and check-ups.
Throughout the study, the research team will closely monitor your health, symptoms, and how you're feeling. This will involve various tests, blood samples, and questionnaires at regular visits. These visits are important for the team to understand how the medicine is working and to make sure you are safe. For some participants, there's a specific part of the study (called a substudy) where you'll receive injections under the skin. This will also involve keeping your current gMG medications, like steroids, at a steady dose for the first 8 weeks.
The total duration of your participation in the study will involve regular visits for treatment and assessments, followed by a period where your health is still monitored even after you stop receiving the study medicine. You will be given a detailed schedule of visits and procedures if you decide to take part, and you will always have the right to withdraw from the study at any time.
Potentiella risker och fördelar
Platser (112)
- Neuromuscular Research Center and ClinicVerifierat postnummerParadise Valley, USA· Rekrytering
- HonorHealth NeurologyVerifierat postnummerScottsdale, USA· Avslutad
- University of Southern CaliforniaVerifierat postnummerLos Angeles, USA· Avslutad
- Stanford UniversitetVerifierat postnummerPalo Alto, USA· Avslutad
- Care Access ResearchVerifierat postnummerPasadena, USA· Rekrytering
- University of Colorado Anschutz Medical CampusVerifierat postnummerAurora, USA· Rekrytering
- Yale New Haven-sjukhusetVerifierat postnummerNew Haven, USA· Rekrytering
- FM Clinical Research, LLC South Florida Neurology Associates, P. A.Verifierat postnummerBoca Raton, Förenta staterna· Rekrytering
- University of Florida Health JacksonvilleVerifierat postnummerJacksonville, USA· Avslutad
- Medsol Clinical Research Center IncVerifierat postnummerPort Charlotte, USA· Rekrytering
- University of South FloridaVerifierat postnummerTampa, USA· Rekrytering
- Augusta UniversityVerifierat postnummerAugusta, USA· Avslutad
Vanliga frågor
What is generalised myasthenia gravis (gMG)?
gMG is a condition where your body's immune system mistakenly attacks parts of your muscles, making them weak and tired easily, affecting many parts of your body.
Vad är nipocalimab?
Nipocalimab is a new medicine being tested to see if it can help improve the symptoms of gMG. It's not yet approved for general use.
Vad är en placebo?
A placebo is a 'dummy' treatment that looks like the actual medicine but doesn't contain any active ingredients. It helps researchers fairly compare the new medicine's effects.
Hur kommer medicinen att ges?
Depending on which group you're in, it could be given through a drip into your vein or as an injection just under your skin.
Kan jag lämna studien om jag ändrar mig?
Ja, du kan välja att lämna studien när som helst, av vilken anledning som helst, utan att det påverkar din medicinska vård.
Hur du får reda på mer
Studiekontakt
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Intresserad av att delta?
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.